UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Ras inhibitor farnesylthiosalicylic acid conjugated with IR783 dye exhibits improved tumor-targeting and altered anti-breast cancer mechanisms in mice Journal article
Huang, Qiu ju, Liao, Guo chao, Zhuang, Xue rong, Yang, Meng lan, Yao, Jing jing, Deng, Jian hua, Zhang, Yan min, Wang, Ying, Qi, Xiao xiao, Pan, Dong feng, Guan, Yang, Huang, Zhi ying, Zhang, Feng xue, Liu, Zhong qiu, Lu, Lin lin. Ras inhibitor farnesylthiosalicylic acid conjugated with IR783 dye exhibits improved tumor-targeting and altered anti-breast cancer mechanisms in mice[J]. Acta Pharmacologica Sinica, 2022, 43(7), 1843-1856.
Authors:  Huang, Qiu ju;  Liao, Guo chao;  Zhuang, Xue rong;  Yang, Meng lan;  Yao, Jing jing; et al.
Favorite | TC[WOS]:5 TC[Scopus]:4  IF:6.9/7.6 | Submit date:2023/01/30
Ampk  Breast Neoplasm  Farnesylthiosalicylic Acid  Ir783  Mtor  Ras Inhibitor  Tumor-targeting  
Elevated risk of radiotherapy-associated second malignant neoplasms in young African American women with breast cancer Journal article
Xie, L., Bao, X., Cai, T., Silva, S., Ma, J., Zhang, Z., Guo, X., Marks, L.. Elevated risk of radiotherapy-associated second malignant neoplasms in young African American women with breast cancer[J]. International Journal of Radiation Oncology, Biology, Physics, 2019, NA-NA.
Authors:  Xie, L.;  Bao, X.;  Cai, T.;  Silva, S.;  Ma, J.; et al.
Favorite | TC[WOS]:4 TC[Scopus]:3  IF:6.4/6.1 | Submit date:2022/06/22
Radiotherapy  Long-term Non-breast Second Malignant Neoplasm  African American  Young Women  Breast Cancer